July 19, 2023
This study is for patients with solid tumors that are progressing after treatment with taxane therapies
March 23, 2023
Hospitals and cancer centers nationwide are opening ComboMATCH on a rolling basis over the next few months
January 5, 2023
This study is for patients who have aggressive, high-grade tumors that put them at higher risk of recurrence after treatment
September 26, 2022
Researchers at ECOG-ACRIN are studying if they can improve results for patients with liver cancer by giving chemotherapy along with drugs that help the body’s immune system fight cancer
June 28, 2022
This trial is for patients who have leukemia cells still in the blood or bone marrow after initial treatment
March 24, 2022
This pilot study will test some exciting new interactive features that ECOG-ACRIN would like to add to the surveys and questionnaires used to evaluate the experiences of young patients
December 15, 2021
This trial is for patients who have cancer cells still in the blood or bone marrow after approximately one year of lenalidomide maintenance therapy following a stem cell transplant
September 20, 2021
This study is for patients with pancreatic cancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation
June 24, 2021
This study will evaluate the effects and safety of green tea catechins in men on active surveillance for prostate cancer
March 3, 2021
This trial is testing if the addition of immunotherapy to the usual treatment will lead to better results for patients with esophagus or gastroesophagus cancer
October 2, 2020
This trial compares two common surveillance methods for people with at least one non-cancerous cyst in the pancreas, to measure which one leads to better outcomes. The study may also uncover findings that could predict the behavior of these cysts.
June 8, 2020
This study is evaluating whether lower doses of chemoradiation will be able to effectively treat early-stage anal squamous cell carcinoma while also decreasing side effects.